C2N Diagnostics EU ApS
CVR 45009092 · Private limited company (ApS) · Active · Medium risk
C2N Diagnostics EU ApS is a Private limited company (ApS), founded on , based in København Ø. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 2.0% over the next 12 months, which is 1.4 times the average for Danish companies. 2 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK -202k and a net result of DKK -140k. CEO: Dr. Joel B. Braunstein.
Bankruptcy risk for C2N Diagnostics EU ApS
1.4 × the average (1.41%) · higher risk than 82% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 45009092
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (2 years)
- Address
- c/o DLA Piper Advokatpartnerselskab, Oslo Plads 2
2100 København Ø - Municipality
- København
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 40k
- Auditor
- Christensen Kjærulff, Statsautoriseret Revisionsaktieselskab
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 1 of 2 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -505.4% |
| Current ratio | 17% |
| Moves (last 2 years) | 1 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 112 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK -130k | DKK -102k | DKK 0 |
| Net profit | DKK -140k | DKK -102k | DKK 0 |
| Equity | DKK -202k | DKK -62k | DKK 0 |
| Total assets | DKK 40k | DKK 40k | DKK 0 |
| Short-term debt | DKK 242k | DKK 102k | – |
| Avg. employees | 1 | – | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Christensen Kjærulff, Statsautoriseret Revisionsaktieselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 177 | ||
| 9 Aug 2024 – 31 Dec 2024 | 213 | Late |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Dr. Joel B. Braunstein | Current | |
| Owner (100%) | C2N Global, Inc | Current | |
| Founder | C2N Global, Inc | Current |
Address history (1 moves)
| c/o DLA Piper Advokatpartnerselskab, Oslo Plads 2, 2100 København Ø | |
| c/o DLA Piper Advokatpartnerselskab, Oslo Plads 2, 2100 København Ø |
Other companies at the same address
- INTERVENTURE A/S Bankrupt
- LA1 ApS Bankrupt
- Lopa Danmark ApS Bankrupt
- MAGNA CHARTA ADVOKATAKTIESELSKAB Bankrupt
- SG FACTORING A/S Bankrupt
- ZENITH ADVOKATER ADVOKATAKTIESELSKAB Bankrupt
- ØSTERPORT TRAFIKSKOLE ApS Bankrupt
- 35 Kalvebod Brygge Tenant ApS Opløst
- 3T Helsingør ApS Active
- AUBADE DENMARK ApS Active
- AZVI Danmark ApS Active
- Aggreko Denmark ApS Active
- Akoya Development Management Company ApS Active
- Akoya Property Investment Company ApS Active
- Allied Universal (Europe) A/S Active
- ApS HVBPD 6 NR. 350 Opløst
- ApS KOMPLEMENTARSELSKABET LULEÅ, SVERIGE Active
- Aros Acquisition ApS Active
- Aros Holdco ApS Active
- B.K. COMPANY ApS Active
- BIG DREAMS ApS Active
- Big Investment ApS Active
- Bird Rides Denmark ApS Opløst
- CNG RP ApS Compulsorily dissolved
- Carbon Removals Denmark A/S Active
Similar companies in København
- AffiCon ApS Valby
- EXTITUTION ApS København Ø
- Coco Sense ApS København NV
- Everllence Denmark A/S København SV
- BioSpectre ApS København V
- Nordic Cell Therapy Group ApS København N
- FiberSure ApS København Ø
- Tasira ApS København N
- Xenogen ApS København S
- Magnalev Core ApS København SV
- Pin Joint ApS København S
- Maglya ApS København Ø
Questions and answers about C2N Diagnostics EU ApS
Has C2N Diagnostics EU ApS gone bankrupt?
No, C2N Diagnostics EU ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of C2N Diagnostics EU ApS?
Our model estimates a bankruptcy risk of 2.0% over the next 12 months (medium risk), which is 1.4 times the average for Danish companies.
Who is the CEO of C2N Diagnostics EU ApS?
Dr. Joel B. Braunstein is the CEO of C2N Diagnostics EU ApS.
Who is the auditor of C2N Diagnostics EU ApS?
C2N Diagnostics EU ApS most recently used Christensen Kjærulff, Statsautoriseret Revisionsaktieselskab.
When was C2N Diagnostics EU ApS founded?
C2N Diagnostics EU ApS was founded on 9 August 2024.
What is the equity of C2N Diagnostics EU ApS?
Equity was DKK -202k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.